CD8A and colonic neoplasm: Importantly, administration (subcutaneous injections) of these cytokines in combination were proven to increase the number and activity of cytotoxic CD8+ cells, to decrease tumor growth and to enhance survival in mice, suggesting that these cytokines can act in concert to improve outcomes in colon cancer (16).